No other R&D analysis tool mines such high quality, historical data to give you answers to key strategic questions.

Answer these questions and more with Pharmapredict:

• Who takes longer to get drugs to market – GSK or Pfizer?
• How long do diabetes drugs spend in clinical trials?
• Which are fastest to market – cancer, biotech or antiviral drugs?

Pharmapredict contains data on all drugs developed since 1980. Each time a drug moves to a new phase of development we record the date that this event takes place. This wealth of data enables Pharmapredict to calculate the average time that a drug spends in each phase of development.

Base your analysis on:

• The development time of a company; how efficient are they?
• The development time of drugs belonging to the same therapeutic group e.g. respiratory drugs
• The development time of drugs belonging to the same specific therapy e.g. asthma drugs
• The development time of all drugs – independent of company or therapy. Give your analysis a global perspective.

Simply select one or many companies or therapies and you will immediately be presented with a Development Time Analysis spreadsheet. Development times for each phase of development are presented so you can benchmark against your competitors and spot strengths and weaknesses.

Reports can be exported to Excel or BizInt SmartCharts for further analysis, ideal for use in reports or presentations.

View results